BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9627806)

  • 41. Phosphocreatine as a possible modulator of the adenylate pool.
    Ronca G; Pezzini A; Conte A; Galbani P; Zucchi R; Ronca-Testoni S
    Adv Exp Med Biol; 1989; 253B():99-106. PubMed ID: 2610149
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
    Patel R; Ford CA; Rodgers L; Rushworth LK; Fleming J; Mui E; Zhang T; Watson D; Lynch V; Mackay G; Sumpton D; Sansom OJ; Vande Voorde J; Leung HY
    Cancer Res; 2022 Jul; 82(14):2565-2575. PubMed ID: 35675421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.
    Maril N; Degani H; Rushkin E; Sherry AD; Cohn M
    Am J Physiol; 1999 Oct; 277(4):C708-16. PubMed ID: 10516101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclocreatine phosphate, an analogue of creatine phosphate, does not improve hypoxic tolerance in mice.
    Artru AA; Michenfelder JD
    J Neurochem; 1982 Oct; 39(4):1198-200. PubMed ID: 7119791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Creatine and creatinine metabolism.
    Wyss M; Kaddurah-Daouk R
    Physiol Rev; 2000 Jul; 80(3):1107-213. PubMed ID: 10893433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The two sides of creatine in cancer.
    Zhang L; Bu P
    Trends Cell Biol; 2022 May; 32(5):380-390. PubMed ID: 34895811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of muscular weakness in rats by a creatine analogue.
    FITCH CD; DINNING JS
    Nature; 1960 Jul; 187():421. PubMed ID: 13823289
    [No Abstract]   [Full Text] [Related]  

  • 48. The effects of magnesium ions and of creatine phosphate on the synthesis of acetylcholine.
    FELDBERG W; HEBB C
    J Physiol; 1947 Mar; 106(1):8-17. PubMed ID: 20241953
    [No Abstract]   [Full Text] [Related]  

  • 49. Measurement of beta-guanidinopropionate and phosphorylated beta-guanidinopropionate in tissues.
    Fitch CD; Chevli R
    Anal Biochem; 1975 Sep; 68(1):196-201. PubMed ID: 1190433
    [No Abstract]   [Full Text] [Related]  

  • 50.
    Coleman-Hulbert AL; Johnson E; Sedore CA; Banse SA; Guo M; Driscoll M; Lithgow GJ; Phillips PC
    MicroPubl Biol; 2020; 2020():. PubMed ID: 31998863
    [No Abstract]   [Full Text] [Related]  

  • 51. [Creatine metabolism; influence of hormonal incretions on the tissular behavior of free and associated creatine aliquot].
    MORGANO G
    Arch Maragliano Patol Clin; 1951; 6(3):449-98. PubMed ID: 14857966
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of the parathyroid on the metabolism of creatine and phosphoric acid: Part I. Phosphate excretion after injections of creatine and parathormone. Part II. Regulation of creatine phosphate after thyroparathyroidectomy, etc.
    Brown M; Imrie CG
    J Physiol; 1932 Jul; 75(3):366-79. PubMed ID: 16994323
    [No Abstract]   [Full Text] [Related]  

  • 53. Unravelling the molecular basis of futile creatine cycling.
    Greenhill C
    Nat Rev Endocrinol; 2021 Jul; 17(7):381. PubMed ID: 34021276
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect on the blood-sugar and blood-phosphate of ingested creatine.
    Stacey RS
    Biochem J; 1933; 27(3):690-2. PubMed ID: 16745145
    [No Abstract]   [Full Text] [Related]  

  • 55. Liposomal Delivery of Cyclocreatine Impairs Cancer Cell Bioenergetics Mediating Apoptosis.
    Ganguly S; Elbayoumi T
    Methods Mol Biol; 2021; 2275():173-186. PubMed ID: 34118038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.
    Ulland TK; Song WM; Huang SC; Ulrich JD; Sergushichev A; Beatty WL; Loboda AA; Zhou Y; Cairns NJ; Kambal A; Loginicheva E; Gilfillan S; Cella M; Virgin HW; Unanue ER; Wang Y; Artyomov MN; Holtzman DM; Colonna M
    Cell; 2017 Aug; 170(4):649-663.e13. PubMed ID: 28802038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.
    Oudman I; Clark JF; Brewster LM
    PLoS One; 2013; 8(1):e52879. PubMed ID: 23326362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral creatine supplementation and skeletal muscle metabolism in physical exercise.
    Mesa JL; Ruiz JR; González-Gross MM; Gutiérrez Sáinz A; Castillo Garzón MJ
    Sports Med; 2002; 32(14):903-44. PubMed ID: 12427051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.
    Ara G; Gravelin LM; Kaddurah-Daouk R; Teicher BA
    In Vivo; 1998; 12(2):223-31. PubMed ID: 9627806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
    Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
    Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.